The National Home Infusion Association (NHIA) is proud to announce that Mitra Gavgani, PharmD is the recipient of the 2025 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) applauds the re-introduction of The Preserving Patient Access to Home Infusion Act – bipartisan, bicameral legislation that will ensure Medicare patients can receive the intravenous (IV) medications they need while at home.
NHIF is proud to announce that Maritza DeGagne, RPh is the recipient of the 2025 Lynn Giglione Women in Leadership Award, which recognizes and honors trail-blazing and emerging women leaders who have demonstrated exemplary service to patients and their peers while promoting the mission of NHIF.
The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2025. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
NHIA submitted comments to CMS on its Draft Medicare Transaction Facilitator (MTF) Agreements, which will be used to implement negotiated prices for drugs under the Medicare Drug Price Negotiation Program.
NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Seats are only open to provider members and are assigned at the organization level.
The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care.
An independent analysis by Magnolia Market Access estimates that changes proposed by NHIA to the Preserving Patient Access to Home Infusion Act to expand Medicare Part B home infusion therapy services coverage to anti-infectives, and bundle payments for disposable supplies with the services payment would generate significant savings for Medicare.
The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, are pleased to announce the addition of Melinta to NHIA’s Future of Infusion Advisory Council (FIAC).
A diverse group of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 1976/H.R. 4104) and increase access to home infusion therapy for Medicare beneficiaries.
Momentum has been building for legislators to address Medicare’s broken home infusion benefit as part of a year-end legislative package. After considerable engagement from NHIA, the groundwork has been laid for Congress to pass the Preserving Patient Access to Home Infusion Act (H.R. 4104; S. 1976) and enhance access to home infusion services for Medicare beneficiaries nationwide.
Registration is now open for the National Home Infusion Association’s 2025 Annual Conference (NHIA 2025), to be held March 29 – April 2, 2025, at the Gaylord National Resort and Convention Center just outside Washington D.C. in National Harbor, MD.
NHIA has developed resources and is urging HHS action in response to the recent operational disruption at Baxter’s North Cove, NC facility due to Hurricane Helene. See the latest resources in NHIA’s IV Fluid Shortage Resource Center.
As part of ongoing quality improvement activities, the National Home Infusion Foundation (NHIF) has released a draft standard definition for measuring home infusion medication adherence.
The National Home Infusion Association (NHIA) has developed a list of medications to serve as a reference when making site of care decisions for patients requiring intravenous (IV) or subcutaneous (SC) infusions. The list of medications reflects current U.S. prescribing practices and was compiled from home infusion providers medication dispensing reports and reviewed by NHIA’s Quality and Standards Committee.
Everyone’s favorite wellness challenge is back! Join the National Home Infusion Foundation and NHIA Staff as we Infuse Wellness across our community this September.
The National Home Infusion Association (NHIA) is proud to announce that Mitra Gavgani, PharmD is the recipient of the 2025 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) applauds the re-introduction of The Preserving Patient Access to Home Infusion Act – bipartisan, bicameral legislation that will ensure Medicare patients can receive the intravenous (IV) medications they need while at home.
NHIF is proud to announce that Maritza DeGagne, RPh is the recipient of the 2025 Lynn Giglione Women in Leadership Award, which recognizes and honors trail-blazing and emerging women leaders who have demonstrated exemplary service to patients and their peers while promoting the mission of NHIF.
The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2025. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
NHIA submitted comments to CMS on its Draft Medicare Transaction Facilitator (MTF) Agreements, which will be used to implement negotiated prices for drugs under the Medicare Drug Price Negotiation Program.
NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Seats are only open to provider members and are assigned at the organization level.
The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care.
An independent analysis by Magnolia Market Access estimates that changes proposed by NHIA to the Preserving Patient Access to Home Infusion Act to expand Medicare Part B home infusion therapy services coverage to anti-infectives, and bundle payments for disposable supplies with the services payment would generate significant savings for Medicare.
The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, are pleased to announce the addition of Melinta to NHIA’s Future of Infusion Advisory Council (FIAC).
A diverse group of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 1976/H.R. 4104) and increase access to home infusion therapy for Medicare beneficiaries.
Momentum has been building for legislators to address Medicare’s broken home infusion benefit as part of a year-end legislative package. After considerable engagement from NHIA, the groundwork has been laid for Congress to pass the Preserving Patient Access to Home Infusion Act (H.R. 4104; S. 1976) and enhance access to home infusion services for Medicare beneficiaries nationwide.
Registration is now open for the National Home Infusion Association’s 2025 Annual Conference (NHIA 2025), to be held March 29 – April 2, 2025, at the Gaylord National Resort and Convention Center just outside Washington D.C. in National Harbor, MD.
NHIA has developed resources and is urging HHS action in response to the recent operational disruption at Baxter’s North Cove, NC facility due to Hurricane Helene. See the latest resources in NHIA’s IV Fluid Shortage Resource Center.
As part of ongoing quality improvement activities, the National Home Infusion Foundation (NHIF) has released a draft standard definition for measuring home infusion medication adherence.
After years playing Rugby at the international level, Lyons, Colorado-based artist Sonny Smith went through several surgeries and eventually total replacement of both knees. But, post-surgery, the left knee experienced persistent infection. Sonny has received antibiotic infusions across every major site of care and favors home infusion.
The National Home Infusion Association (NHIA) has developed a list of medications to serve as a reference when making site of care decisions for patients requiring intravenous (IV) or subcutaneous (SC) infusions. The list of medications reflects current U.S. prescribing practices and was compiled from home infusion providers medication dispensing reports and reviewed by NHIA’s Quality and Standards Committee.
